Published in Chest on August 01, 2002
Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax (2004) 1.93
Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study. Qual Saf Health Care (2007) 1.36
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur J Heart Fail (2012) 0.93
Factors associated with length of stay in hospital for suspected community-acquired pneumonia. Can Respir J (2006) 0.84
Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia. BMC Med Inform Decis Mak (2016) 0.80